The purpose of this open-label, single arm, multicenter extension study is to evaluate the long-term safety and tolerability of inclisiran in participants with HeFH or HoFH who have completed the ORION-16 or ORION-13 studies.
Heterozygous or Homozygous Familial Hypercholesterolemia
The purpose of this open-label, single arm, multicenter extension study is to evaluate the long-term safety and tolerability of inclisiran in participants with HeFH or HoFH who have completed the ORION-16 or ORION-13 studies.
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies
-
Excel Medical Clinical Trials LLC, Boca Raton, Florida, United States, 33434
Icahn School of Med at Mt Sinai ., New York, New York, United States, 10029
Cincinnati Childrens Hospital MC ., Cincinnati, Ohio, United States, 45229-3039
Primary Childrens Medical Center Research, Salt Lake City, Utah, United States, 84113
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
12 Years to
ALL
No
Novartis Pharmaceuticals,
Novartis Pharmaceuticals, STUDY_DIRECTOR, Novartis Pharmaceuticals
2028-06-30